No abstract

Objective: Treadmill exercise stress testing for identifying patients with a higher likelihood of coronary artery disease (CAD) before elective coronary angiography is recommended in the current guidelines. In this study, we aimed to evaluate the changes in the hematological parameters before and after exercise stress test in relation with the presence of CAD. Methods:A total of 113 patients with chest pain who underwent treadmill exercise testing and coronary angiography were included in this study. Conclusions: Neutrophil to lymphocyte ratio is an important inflammatory marker that can contribute to treadmill ECG testing in predicting CAD.

Patients with RMS have increased platelet activity reflected as elevated MPV; and the coexistence of severe mitral regurgitation and presence of left atrial spontaneous echo contrast are determinants of this increment.

Alternative and complementary products were common in patients admitted to outpatient cardiology clinics. Female gender, advanced age, higher education level, drug intake, and having a chronic illness were predisposing factors.

Background: Resolvin D1 (RvD1) can play a determining role in inflammatory cell migration and reduce the expression of inflammatory cytokines to enhance cardioprotection. The aim of this study was to compare serum RvD1 levels in patients with ST-elevation myocardial infarction (STEMI) and in individuals with normal coronary arteries (NCA); and to evaluate the association between serum RvD1 levels and prognostic markers of STEMI. Methods: A total of 140 individuals, consisting of 88 patients diagnosed with the indication of STEMI and 52 healthy individuals with NCA, were included. Results: Regression analysis revealed that the RvD1 levels were independently associated with the STEMI. While RvD1 levels were negatively correlated with high-sensitivity C-reactive protein, pro-brain natriuretic peptide, peak troponin, and the Thrombolysis in Myocardial Infarction (TIMI) thrombus grade, they were positively correlated with left ventricular ejection fraction. A RvD1 cut-off value 5.07 (ng/ml) was effective in predicting STEMI with a sensitivity of 79.5% and specificity of 96.2%. Conclusion: Serum Resolvin D1 levels were detected to be lower in the group with STEMI compared to the control group. Admission RvD1 levels were associated with poor prognostic markers of STEMI.